A detailed history of Gladius Capital Management LP transactions in Johnson & Johnson stock. As of the latest transaction made, Gladius Capital Management LP holds 12,744 shares of JNJ stock, worth $2 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
12,744
Previous 15,264 16.51%
Holding current value
$2 Million
Previous $2.23 Million 7.4%
% of portfolio
1.24%
Previous 2.25%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$145.48 - $167.38 $366,609 - $421,797
-2,520 Reduced 16.51%
12,744 $2.07 Million
Q2 2024

Jul 18, 2024

BUY
$144.38 - $157.78 $1.52 Million - $1.66 Million
10,544 Added 223.39%
15,264 $2.23 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $105,860 - $110,988
-682 Reduced 12.62%
4,720 $746,000
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $3.93 Million - $4.29 Million
-26,972 Reduced 83.31%
5,402 $846,000
Q3 2023

Oct 10, 2023

BUY
$155.75 - $174.48 $5.04 Million - $5.65 Million
32,374 New
32,374 $5.04 Million
Q1 2023

Dec 18, 2023

SELL
$151.05 - $180.26 $2.15 Million - $2.56 Million
-14,205 Reduced 43.88%
18,169 $2.82 Million
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $2 Million - $2.39 Million
13,234 Added 268.17%
18,169 $2.82 Million
Q4 2022

Dec 18, 2023

SELL
$160.2 - $179.79 $4.4 Million - $4.93 Million
-27,439 Reduced 84.76%
4,935 $871,000
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $2.26 Million - $2.54 Million
-14,131 Reduced 74.12%
4,935 $872,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $2.64 Million - $2.94 Million
16,353 Added 602.76%
19,066 $3.12 Million
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $225,038 - $248,881
1,338 Added 97.31%
2,713 $482,000
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $315,963 - $358,820
-1,998 Reduced 59.24%
1,375 $244,000
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $498,976 - $553,632
3,200 Added 1849.71%
3,373 $578,000
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $26,001 - $28,894
161 Added 1341.67%
173 $28,000
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $1,913 - $2,052
12 New
12 $2,000
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $275,865 - $316,648
-2,012 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $282,444 - $309,505
2,012 New
2,012 $300,000
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $605,278 - $730,741
-4,699 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $522,246 - $723,599
4,699 New
4,699 $617,000
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $2.75 Million - $3.16 Million
-21,595 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $1.56 Million - $1.75 Million
12,313 Added 132.65%
21,595 $2.79 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $4.63 Million - $5.1 Million
-35,334 Reduced 79.2%
9,282 $1.29 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $5.88 Million - $6.54 Million
-46,789 Reduced 51.19%
44,616 $0
Q4 2018

Feb 15, 2019

BUY
$122.84 - $147.84 $10.7 Million - $12.8 Million
86,715 Added 1848.93%
91,405 $11.8 Million
Q3 2018

Nov 15, 2018

SELL
$121.58 - $142.88 $682,428 - $801,985
-5,613 Reduced 54.48%
4,690 $0
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $1.23 Million - $1.36 Million
10,303 New
10,303 $1.25 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.